Pulmonary Pharmacology

Pulmonary Pharmacology, Volume 98 provides in-depth reviews on the latest progresses about respiratory drug discovery and development. Topics covered in this volume include corticosteroids, monoclonal antibodies, tyrosine kinase inhibitors and phosphodiesterase inhibitors for the treatments of asthma, COPD or pulmonary fibrosis, with perspective on the development of novel therapeutic strategies such as renin-angiotensin system modulators, mitochondrial function modulators, and non-antibacterial macrolides. Part of the volume is devoted to senotherapy for lung ageing in respiratory diseases, and novel pulmonary delivery technologies, including inhaled biologics.

• Provides accurate reviews from leading experts on the topic of pulmonary pharmacology
• Each chapter of the volume provides consolidated graphical materials for ease of reading for the audience
• Provides the latest insights and future perspectives on the drug discovery and development for respiratory diseases

Dettagli